Family · Pharmaceutical analytical standards
Drostanolone
An androgenic steroid derived from dihydrotestosterone (2α-methyl-DHT), described in 1959 and introduced in the United States in 1961 as the propionate ester to treat advanced inoperable breast cancer in women. This family brings together the active ingredient.
Did you know?It was first described in the same scientific paper that introduced oxymetholone; being a DHT derivative, it cannot be converted into oestrogens by aromatase.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
